Agios Pharmaceuticals, Inc.

Healthcare · Biotechnology

31.30$ -1.7% vs. previous close Closing price · As of: Oct 5, 2026

Statements

Balance Sheet

Agios Pharmaceuticals, Inc. (AGIO) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 1,108 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet AGIO
Line item	Q3 16	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Total Assets	672	619	557	761	687	614	1,040	998	929	858	822	784	699	891	800	976	908	853	2,488	1,875	1,541	1,438	1,336	1,252	1,180	1,239	1,151	1,085	1,007	937	850	773	1,792	1,663	1,556	1,471	1,386	1,297	1,185	1,108
Current Assets	601	560	507	605	528	445	803	754	696	614	557	534	490	612	587	846	669	637	2,355	1,703	1,305	1,064	975	870	785	833	792	757	704	834	664	632	1,074	966	969	1,019	1,033	942	835	718
Cash	286	574	200	139	133	568	995	210	156	805	103	84	82	81	89	296	105	127	1,888	969	400	203	80	89	122	139	104	85	64	88	119	85	254	76	79	81	93	89	114	100
Cash & Short-Term Investments	579	574	480	586	508	568	995	717	670	805	525	495	452	565	529	790	606	573	2,336	1,673	1,266	1,020	924	819	728	783	739	703	647	777	598	570	1,005	894	893	939	953	854	737	618
Receivables	12	8.3	15	5.6	5.1	3.8	4.9	21	8.3	10	11	15	12	15	20	18	23	25	–	8.1	7.0	4.4	5.9	4.3	5.6	2.2	1.8	2.3	1.2	2.8	3.5	3.8	3.1	4.1	3.3	5.0	5.0	11	16	20
Inventory	0.0	-32	0.0	-0.8	-0.9	-144	-212	–	0.9	0.9	2.3	4.7	5.8	7.3	9.8	11	11	15	–	–	–	16	2.5	4.1	5.2	8.5	11	16	17	19	23	24	26	28	30	31	32	33	35	30
Property, Plant & Equipment	26	25	24	25	24	24	24	24	25	24	24	23	24	31	34	34	33	32	112	108	25	29	29	27	25	23	21	20	74	–	–	–	–	–	–	–	–	–	–	–
Goodwill	0.0	0.0	0.0	0.0	0.0	0.0	0.0	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Intangible Assets	0.0	0.0	0.0	0.0	0.0	0.0	0.0	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Total Liabilities	271	261	250	252	237	239	175	175	169	171	202	251	250	250	174	418	428	453	192	153	147	146	128	128	130	138	115	121	120	126	106	113	165	122	89	102	101	104	76	82
Current Liabilities	78	88	82	94	88	95	75	85	85	94	81	90	92	93	70	64	70	94	97	61	58	60	46	48	54	63	45	55	58	68	52	63	119	81	52	70	75	82	59	70
Short-Term Debt	–	154	–	–	–	126	82	–	–	60	9.1	6.4	7.3	6.9	6.8	7.0	7.2	7.4	8.3	9.8	10	11	12	12	13	14	14	14	15	15	15	16	16	17	17	18	18	18	19	19
Accounts Payable	15	17	16	23	18	23	18	17	17	18	12	15	22	22	19	15	13	18	51	7.7	10	17	12	7.8	10	19	8.7	12	13	9.8	11	10	17	17	14	18	20	18	14	16
Long-Term Debt	0.0	0.0	0.0	0.0	0.0	0.0	0.0	–	–	–	66	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Shareholders' Equity	401	359	307	509	450	376	866	823	760	688	620	533	448	641	625	558	480	400	2,297	1,722	1,395	1,292	1,207	1,124	1,050	1,101	1,037	964	887	811	744	661	1,627	1,541	1,467	1,370	1,284	1,193	1,109	1,026
Retained Earnings	-427	-483	-550	-633	-710	-798	-849	-918	-1,013	-1,105	-1,198	-1,308	-1,414	-1,516	-1,556	-1,647	-1,746	-1,843	31	-55	-144	-239	-334	-425	-507	-471	-552	-635	-727	-823	-904	-1,000	-52	-149	-238	-350	-454	-562	-661	-762
Shares Outstanding	39	42	42	47	48	49	56	58	58	58	58	59	59	64	69	69	69	69	70	61	57	54	55	55	55	55	55	56	56	56	56	57	58	57	57	58	58	58	59	59

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings